These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4283625)

  • 1. Components of the fibrinolytic system in synovial joints. Normal bovine compared with normal and abnormal human synovial joints.
    Caughey DE; Highton TC
    Ann Rheum Dis; 1967 Jul; 26(4):297-305. PubMed ID: 4283625
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between synovial joint and fibrinolytic activity of synovial fluid.
    Aoike I; Tominaga T; Horiuchi H; Arai T; Mizue S
    Bull Tokyo Med Dent Univ; 1966 Jun; 13(2):77-95. PubMed ID: 4224976
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
    Saxne T; Lecander I; Geborek P
    J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of surfactant proteins A, B, C, and D in articular cartilage, synovial membrane and synovial fluid of healthy as well as patients with osteoarthritis and rheumatoid arthritis.
    Hartjen N; Bräuer L; Reiß B; Claassen H; Beileke S; Garreis F; Hoogeboom S; Tsokos M; Etzold S; Müller-Hilke B; Gelse K; Müller T; Goldring MB; Paulsen F; Schicht M
    PLoS One; 2018; 13(9):e0203502. PubMed ID: 30235245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic activity in the synovial membrane of osteoarthritis.
    Matucci-Cerinic M; Lombardi A; Lotti T; Pignone A; Senesi C; Buzzi R; Aglietti P; Partsch G; Cagnoni M
    Br J Rheumatol; 1990 Aug; 29(4):249-53. PubMed ID: 2116205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of human cartilage by synovial fluid but not cytokines in vitro.
    Hollander AP; Atkins RM; Eastwood DM; Dieppe PA; Elson CJ
    Ann Rheum Dis; 1991 Jan; 50(1):57-8. PubMed ID: 1994871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation.
    Dingle JT; Page Thomas DP; Hazleman B
    Int J Tissue React; 1987; 9(4):349-54. PubMed ID: 3497901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of matrices in cartilage synovial fluid combine under moderate & high loadings.
    Saxena RK; Agarwal K; Sahay KB; Guha SK; Dave PK
    Indian J Med Res; 1998 Mar; 107():123-7. PubMed ID: 9599951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis.
    Busso N; Hamilton JA
    Arthritis Rheum; 2002 Sep; 46(9):2268-79. PubMed ID: 12355473
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis?
    Saxne T; Wollheim FA; Pettersson H; Heinegård D
    Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1447-8. PubMed ID: 3121058
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased levels of thymosin β4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin β4 with other factors that are involved in inflammation and bone erosion in joints.
    Choi HM; Lee YA; Yang HI; Yoo MC; Kim KS
    Int J Rheum Dis; 2011 Oct; 14(4):320-4. PubMed ID: 22004227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage.
    Di Cesare PE; Carlson CS; Stolerman ES; Hauser N; Tulli H; Paulsson M
    J Orthop Res; 1996 Nov; 14(6):946-55. PubMed ID: 8982138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid.
    Inman RD; Harpel PC
    J Rheumatol; 1986 Jun; 13(3):535-7. PubMed ID: 2942685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.
    Mânsson B; Gülfe A; Geborek P; Heinegård D; Saxne T
    Ann Rheum Dis; 2001 Jan; 60(1):27-31. PubMed ID: 11114278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis.
    Fujii W; Kawahito Y; Nagahara H; Kukida Y; Seno T; Yamamoto A; Kohno M; Oda R; Taniguchi D; Fujiwara H; Ejima A; Kishida T; Mazda O; Ashihara E
    Arthritis Rheumatol; 2015 Nov; 67(11):2888-96. PubMed ID: 26213210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in sulfation patterns of chondroitin sulfate in equine articular cartilage and synovial fluid in response to aging and osteoarthritis.
    Brown MP; West LA; Merritt KA; Plaas AH
    Am J Vet Res; 1998 Jun; 59(6):786-91. PubMed ID: 9622753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic factor from synovial fluid resembling that from tumours.
    Brown RA; Weiss JB; Tomlinson IW; Phillips P; Kumar S
    Lancet; 1980 Mar; 1(8170):682-5. PubMed ID: 6103093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix proteins: potentials as body fluid markers of changes in the metabolism of cartilage and bone in arthritis.
    Saxne T; Heinegård D
    J Rheumatol Suppl; 1995 Feb; 43():71-4. PubMed ID: 7752144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroitin sulphate in the normal and rheumatoid synovial fluid.
    Seppälä PO; Kärkkäinen J; Lehtonen A; Mäkisara P
    Clin Chim Acta; 1972 Feb; 36(2):549-53. PubMed ID: 5008811
    [No Abstract]   [Full Text] [Related]  

  • 20. Deposition of fibronectin in articular cartilage of canine osteoarthritic joints.
    Burton-Wurster N; Lust G
    Am J Vet Res; 1985 Dec; 46(12):2542-5. PubMed ID: 4083590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.